Cargando…
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer
BACKGROUND: The muscle invasive form of urothelial bladder cancer (UBC) is a deadly disease. Currently, the therapeutic approach of UBC is mostly based on surgery and standard chemotherapy. Biomarkers to establish appropriate drugs usage are missing. Deficiency of the tumor suppressor CCDC6 determin...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381716/ https://www.ncbi.nlm.nih.gov/pubmed/30786932 http://dx.doi.org/10.1186/s13046-019-1087-1 |